BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 26187794)

  • 1. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
    Sehdev A; O'Neil BH
    Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
    Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
    Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer: feasibility in everyday practice?
    Herszényi L; Farinati F; Miheller P; Tulassay Z
    Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
    Gronich N; Rennert G
    Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of Colorectal Cancer.
    Katona BW; Weiss JM
    Gastroenterology; 2020 Jan; 158(2):368-388. PubMed ID: 31563626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaco and diet based prostate cancer prevention].
    Eisinger F; Cancel-Tassin G; Azzouzi AR; Gravis G; Rossi D; Cussenot O
    Bull Cancer; 2013 May; 100(5):497-507. PubMed ID: 23694994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for the prevention of colorectal cancer.
    Garcia-Albeniz X; Chan AT
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
    BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis.
    Dulai PS; Singh S; Marquez E; Khera R; Prokop LJ; Limburg PJ; Gupta S; Murad MH
    BMJ; 2016 Dec; 355():i6188. PubMed ID: 27919915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?
    Arai J; Suzuki N; Niikura R; Ooki D; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Ishibashi R; Aoki T; Tsuji Y; Yamamichi N; Hayakawa Y; Fujishiro M
    Dig Dis Sci; 2022 Nov; 67(11):5227-5238. PubMed ID: 35230578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colorectal cancer: Past, present, and future.
    Umezawa S; Higurashi T; Komiya Y; Arimoto J; Horita N; Kaneko T; Iwasaki M; Nakagama H; Nakajima A
    Cancer Sci; 2019 Oct; 110(10):3018-3026. PubMed ID: 31361372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.
    Boursi B; Arber N
    Curr Pharm Des; 2007; 13(22):2274-82. PubMed ID: 17692000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
    Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and intervention trials for colorectal cancer.
    Komiya M; Fujii G; Takahashi M; Iigo M; Mutoh M
    Jpn J Clin Oncol; 2013 Jul; 43(7):685-94. PubMed ID: 23613189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study.
    Hoffmeister M; Chang-Claude J; Brenner H
    Int J Cancer; 2007 Sep; 121(6):1325-30. PubMed ID: 17487832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan.
    Miller BF; Thyfault JP
    Physiology (Bethesda); 2020 Sep; 35(5):338-347. PubMed ID: 32783612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention.
    Moyad MA; Vogelzang NJ
    Asian J Androl; 2015; 17(5):783-91. PubMed ID: 25657084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.